Literature DB >> 36273006

Single-cell transcriptomic analysis highlights origin and pathological process of human endometrioid endometrial carcinoma.

Xiaojun Ren1,2, Jianqing Liang3,4, Yiming Zhang3,4, Ning Jiang3,4, Yuhui Xu1,2, Mengdi Qiu3,4, Yiqin Wang1,2, Bing Zhao5,6, Xiaojun Chen7,8.   

Abstract

Endometrial cancers are complex ecosystems composed of cells with distinct phenotypes, genotypes, and epigenetic states. Current models do not adequately reflect oncogenic origin and pathological progression in patients. Here we use single-cell RNA sequencing to profile cells from normal endometrium, atypical endometrial hyperplasia, and endometrioid endometrial cancer (EEC), which altogether represent the step-by-step development of endometrial cancer. We find that EEC originates from endometrial epithelial cells but not stromal cells, and unciliated glandular epithelium is the source of EEC. We also identify LCN2 + /SAA1/2 + cells as a featured subpopulation of endometrial tumorigenesis. Finally, the stromal niche and immune environment changes during EEC progression are described. This study elucidates the evolution of cell populations in EEC development at single-cell resolution, which would provide a direction to facilitate EEC research and diagnosis.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36273006     DOI: 10.1038/s41467-022-33982-7

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  55 in total

1.  The tumor microenvironment at a glance.

Authors:  Frances R Balkwill; Melania Capasso; Thorsten Hagemann
Journal:  J Cell Sci       Date:  2012-12-01       Impact factor: 5.285

Review 2.  Endometrial cancer.

Authors:  Philippe Morice; Alexandra Leary; Carien Creutzberg; Nadeem Abu-Rustum; Emile Darai
Journal:  Lancet       Date:  2015-09-06       Impact factor: 79.321

Review 3.  Stem cells in human endometrium and endometrial carcinoma.

Authors:  Irene Cervelló; Cristina Mirantes; Xavier Santamaria; Xavier Dolcet; Xavier Matias-Guiu; Carlos Simón
Journal:  Int J Gynecol Pathol       Date:  2011-07       Impact factor: 2.762

Review 4.  Stem cells in endometrium and endometrial cancer: accumulating evidence and unresolved questions.

Authors:  Satoru Kyo; Yoshiko Maida; Masaki Inoue
Journal:  Cancer Lett       Date:  2011-06-17       Impact factor: 8.679

5.  Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage.

Authors:  Kiyoko Kato; Tomoka Takao; Ayumi Kuboyama; Yoshihiro Tanaka; Tatsuhiro Ohgami; Shinichiro Yamaguchi; Sawako Adachi; Tomoko Yoneda; Yousuke Ueoka; Keiji Kato; Shinichi Hayashi; Kazuo Asanoma; Norio Wake
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

6.  Stem cell-like properties of the endometrial side population: implication in endometrial regeneration.

Authors:  Hirotaka Masuda; Yumi Matsuzaki; Emi Hiratsu; Masanori Ono; Takashi Nagashima; Takashi Kajitani; Toru Arase; Hideyuki Oda; Hiroshi Uchida; Hironori Asada; Mamoru Ito; Yasunori Yoshimura; Tetsuo Maruyama; Hideyuki Okano
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

7.  Two pathogenetic types of endometrial carcinoma.

Authors:  J V Bokhman
Journal:  Gynecol Oncol       Date:  1983-02       Impact factor: 5.482

Review 8.  Classification of endometrial carcinoma: more than two types.

Authors:  Rajmohan Murali; Robert A Soslow; Britta Weigelt
Journal:  Lancet Oncol       Date:  2014-06       Impact factor: 41.316

9.  Endometrial Axin2+ Cells Drive Epithelial Homeostasis, Regeneration, and Cancer following Oncogenic Transformation.

Authors:  Shafiq M Syed; Manish Kumar; Arnab Ghosh; Florence Tomasetig; Ayesha Ali; Renee M Whan; Dariusz Alterman; Pradeep S Tanwar
Journal:  Cell Stem Cell       Date:  2019-12-26       Impact factor: 24.633

10.  Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006.

Authors:  T Evans; O Sany; P Pearmain; R Ganesan; A Blann; S Sundar
Journal:  Br J Cancer       Date:  2011-04-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.